Stay updated on IV ABBV-383 Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the IV ABBV-383 Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IV ABBV-383 Combo in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New and updated entries in the Record History show changes to the Study Status and related details for NCT05259839. These updates reflect changes in recruitment and ongoing study activity.
    Difference
    0.1%
    Check dated 2025-11-03T01:20:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    10%
    Check dated 2025-10-05T10:24:00.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-28T03:20:41.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, indicating a minor maintenance release. The Back to Top link was removed.
    Difference
    0.6%
    Check dated 2025-09-13T17:36:33.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.6%
    Check dated 2025-09-06T15:14:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has added significant details regarding study statuses and locations, including the facility name and the sponsor AbbVie, while removing references to specific locations and a previous sponsor, TeneoOne Inc.
    Difference
    36%
    Check dated 2025-08-30T11:53:05.000Z thumbnail image

Stay in the know with updates to IV ABBV-383 Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IV ABBV-383 Combo in Multiple Myeloma Clinical Trial page.